Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.

Ricci A, Coppo E, Barbieri R, Debbia EA, Marchese A.

J Chemother. 2017 Apr;29(2):67-73. doi: 10.1080/1120009X.2016.1195069. Epub 2016 Jun 10.

PMID:
27285830
2.
3.

Characterization of fluoroquinolone-resistant Escherichia coli causing septicemic colibacillosis in calves in Italy: emergence of a multiresistant O78 clonal group.

Marchese A, Coppo E, Barbieri R, Zoppi S, Pruzzo C, Rossi F, Bergagna S, Dondo A, Debbia E.

Microb Drug Resist. 2012 Feb;18(1):94-9. doi: 10.1089/mdr.2011.0053. Epub 2011 Oct 24.

PMID:
22022869
4.
5.

Antimicrobial effect of MTAD, Tetraclean, Cloreximid, and sodium hypochlorite on three common endodontic pathogens.

Giardino L, Savoldi E, Ambu E, Rimondini R, Palezona A, Debbia EA.

Indian J Dent Res. 2009 Jul-Sep;20(3):391. doi: 10.4103/0970-9290.57353.

6.
7.

Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy).

Castanheira M, Debbia E, Marchese A, Jones RN.

J Chemother. 2009 Feb;21(1):98-100. No abstract available.

PMID:
19297281
8.

The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation.

Cagnacci S, Grasso R, Marchese A, Corvò R, Debbia E, Rossi L.

Open Microbiol J. 2008;2:66-73. doi: 10.2174/1874285800802010066. Epub 2008 May 23.

9.

Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC).

Cassanelli C, Marchese A, Cagnacci S, Debbia EA.

Open Microbiol J. 2008;2:32-7. doi: 10.2174/1874285800802010032. Epub 2008 Apr 15.

10.

European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A.

J Clin Microbiol. 2008 Aug;46(8):2605-12. doi: 10.1128/JCM.00640-08. Epub 2008 Jun 25.

11.

Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.

Debbia EA, Maioli E, Roveta S, Marchese A.

J Chemother. 2008 Apr;20(2):186-94.

PMID:
18467244
13.

Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial.

Rodloff AC, Leclercq R, Debbia EA, Cantón R, Oppenheim BA, Dowzicky MJ.

Clin Microbiol Infect. 2008 Apr;14(4):307-14. doi: 10.1111/j.1469-0691.2007.01943.x. Epub 2008 Feb 2.

14.

In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.

Roveta S, Marchese A, Debbia EA, Bandettini R.

Int J Antimicrob Agents. 2008 Feb;31(2):185-7. Epub 2007 Dec 21. No abstract available.

PMID:
18082375
15.

Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.

Roveta S, Marchese A, Debbia EA.

Chemotherapy. 2008;54(1):43-9. Epub 2007 Dec 10.

PMID:
18073470
16.

Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.

Cagnacci S, Gualco L, Roveta S, Mannelli S, Borgianni L, Docquier JD, Dodi F, Centanaro M, Debbia E, Marchese A, Rossolini GM.

J Antimicrob Chemother. 2008 Feb;61(2):296-300. Epub 2007 Dec 6.

PMID:
18065411
17.

Comparative evaluation of antimicrobial efficacy of sodium hypochlorite, MTAD, and Tetraclean against Enterococcus faecalis biofilm.

Giardino L, Ambu E, Savoldi E, Rimondini R, Cassanelli C, Debbia EA.

J Endod. 2007 Jul;33(7):852-5. Epub 2007 Apr 2.

PMID:
17804328
18.

Periodontal disease and coronary heart disease: an epidemiological and microbiological study.

Latronico M, Segantini A, Cavallini F, Mascolo A, Garbarino F, Bondanza S, Debbia EA, Blasi G.

New Microbiol. 2007 Jul;30(3):221-8.

19.
20.

In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens.

Maioli E, Marchese A, Roveta S, Cagnacci S, Cavallini F, Cassanelli C, Gualco L, Debbia EA.

J Chemother. 2007 Apr;19(2):152-60.

PMID:
17434823
21.

Records matching model for data survey on applied and experimental microbiology.

Reina SA, Reina VM, Debbia EA.

New Microbiol. 2007 Jan;30(1):35-44.

22.

Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.

Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, Schito AM, Marchese A.

Int J Antimicrob Agents. 2007 Feb;29(2):179-84. Epub 2006 Dec 18.

PMID:
17175140
23.

Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system.

Roveta S, Marchese A, Debbia EA.

J Chemother. 2006 Feb;18(1):12-9.

PMID:
16572888
24.

Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).

Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G, Jones RN; SENTRY Antimicrobial Surveillance Program (2001-2004).

Diagn Microbiol Infect Dis. 2006 Mar;54(3):157-64. Epub 2006 Jan 19.

PMID:
16423493
25.

Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders.

Debbia EA, Dolcino M, Marchese A, Piazzi A, Berio A.

New Microbiol. 2004 Oct;27(4):361-7.

PMID:
15646050
26.

In vitro activity of ertapenem against selected respiratory pathogens.

Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC.

J Antimicrob Chemother. 2004 Nov;54(5):944-51. Epub 2004 Oct 7.

PMID:
15472001
27.
28.

Pleiotropic effect of sodium arsenite on Escherichia coli.

Gualco L, Roveta S, Marchese A, Debbia EA.

Res Microbiol. 2004 May;155(4):275-82.

PMID:
15142625
29.
30.

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms.

Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:95-100.

PMID:
14527779
31.

In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.

Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9.

PMID:
14527772
32.

Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.

Schito AM, Schito GC, Debbia E, Russo G, Liñares J, Cercenado E, Bouza E.

J Chemother. 2003 Jun;15(3):226-34.

PMID:
12868547
33.
34.

Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.

Dolcino M, Zoratti A, Debbia EA, Schito GC, Marchese A.

Antimicrob Agents Chemother. 2002 Dec;46(12):4022-5.

35.

Microbial epidemiology patterns of surgical infection pathogens.

Debbia EA, Schito GC, Gualco L, Tonoli E, Dolcino M, Marchese A.

J Chemother. 2001 Nov;13 Spec No 1(1):84-8. Review.

PMID:
11936386
36.

Epidemiology of major respiratory pathogens.

Debbia EA, Schito GC, Zoratti A, Gualco L, Tonoli E, Marchese A.

J Chemother. 2001 Nov;13 Spec No 1(1):205-10. Review.

PMID:
11936367
37.
38.

In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy.

Marchese A, Debbia EA, Schito GC.

Clin Microbiol Infect. 1999 Aug;5(8):488-495.

39.

Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens.

Marchese A, Debbia EA, Bryskier A, Schito GC.

Clin Microbiol Infect. 1999 May;5(5):282-287. No abstract available.

40.

Antibiotic persistence: the role of spontaneous DNA repair response.

Debbia EA, Roveta S, Schito AM, Gualco L, Marchese A.

Microb Drug Resist. 2001 Winter;7(4):335-42.

PMID:
11822773
41.

[Bacterial synergy in postsurgical infective complications in gynecology].

Debbia EA, Marchese A, Schito GC.

Minerva Ginecol. 2000 Dec;52(12 Suppl 1):135-8. Italian. No abstract available.

PMID:
11526682
42.

[Emergence of drug-resistant gram-positive pathogenic bacteria].

Marchese A, Schito GC, Debbia EA.

J Chemother. 2000 Jul;12 Suppl 2:12-4. Italian.

PMID:
11428095
43.

Evaluation of spontaneous contamination of ocular medications.

Marchese A, Bozzolasco M, Gualco L, Schito GC, Debbia EA.

Chemotherapy. 2001 Jul-Aug;47(4):304-8.

PMID:
11399868
44.

Evolution of antibiotic resistance in gram-positive pathogens.

Marchese A, Schito GC, Debbia EA.

J Chemother. 2000 Dec;12(6):459-62.

PMID:
11154025
45.

Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project.

Marchese A, Debbia EA, Schito GC.

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:11-5.

PMID:
10997594
46.

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.

Schito GC, Debbia EA, Marchese A.

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:3-9.

PMID:
10997593
47.

Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy.

Marchese A, Tonoli E, Balistreri G, Debbia E, Schito GC.

Microb Drug Resist. 2000 Summer;6(2):163-70.

PMID:
10990272
48.

Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe.

Debbia EA, Shito GC, Pesce A, Marchese A.

Infection. 1999;27 Suppl 2:S9-12.

PMID:
10885819
50.

[Peptide antibiotics].

Debbia EA.

Recenti Prog Med. 2000 Mar;91(3):106-8. Review. Italian. No abstract available.

PMID:
10763339

Supplemental Content

Loading ...
Support Center